Literature DB >> 28503554

Multimodality imaging of intrahepatic cholangiocarcinoma.

Kelly Fábrega-Foster1, Mounes Aliyari Ghasabeh1, Timothy M Pawlik2, Ihab R Kamel1.   

Abstract

Intrahepatic cholangiocarcinomas account for approximately 20% of cases of cholangiocarcinomas. Three growth patterns or morphologic subtypes exist, including mass-forming, periductal-infiltrating, and intraductal-growth subtypes. Knowledge of these morphologic subtypes and their radiologic appearance aids in timely diagnosis, a key to optimizing patient outcomes. The morphologic variability of intrahepatic cholangiocarcinomas has a direct impact on the diagnostic sensitivity and specificity of various diagnostic imaging modalities, including ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP), and positron emission tomography (PET). The following review emphasizes optimal imaging technique for each of these modalities and reviews the imaging appearance of each morphologic subtype of intrahepatic cholangiocarcinoma.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; intraductal cholangiocarcinoma; mass-forming cholangiocarcinoma; periductal-infiltrating cholangiocarcinoma

Year:  2017        PMID: 28503554      PMCID: PMC5411278          DOI: 10.21037/hbsn.2016.12.10

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  50 in total

1.  Intrahepatic peripheral cholangiocarcinoma: CT evaluation.

Authors:  C Valls; A Gumà; I Puig; A Sanchez; E Andía; T Serrano; J Figueras
Journal:  Abdom Imaging       Date:  2000 Sep-Oct

2.  Portal vein invasion by intrahepatic peripheral cholangiocarcinoma: a rare cause of portal hypertension.

Authors:  P Soyer; J P Pelage; S H Zidi; M Boudiaf; R Rymer
Journal:  AJR Am J Roentgenol       Date:  1998-11       Impact factor: 3.959

3.  The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures.

Authors:  Hyun Jeong Park; Seong Hyun Kim; Kyung Mi Jang; Seo-youn Choi; Soon Jin Lee; Dongil Choi
Journal:  Eur Radiol       Date:  2014-02-02       Impact factor: 5.315

4.  The application of intraoperative ultrasound during partial hepatectomy for the accurate detection and removal of intrahepatic bile duct stones.

Authors:  Guoping Xing; Gong Chen; Xiaobao Peng
Journal:  Cell Biochem Biophys       Date:  2011-11       Impact factor: 2.194

5.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

Authors:  Y Zhang; M Uchida; T Abe; H Nishimura; N Hayabuchi; Y Nakashima
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

6.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

7.  Intrahepatic peripheral cholangiocarcinoma: two-phased dynamic incremental CT and pathologic correlation.

Authors:  H Honda; H Onitsuka; K Yasumori; T Hayashi; K Ochiai; M Gibo; E Adachi; T Matsumata; K Masuda
Journal:  J Comput Assist Tomogr       Date:  1993 May-Jun       Impact factor: 1.826

8.  Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.

Authors:  Lei Jiang; Hui Tan; Cedric M Panje; Haojun Yu; Yan Xiu; Hongcheng Shi
Journal:  Clin Nucl Med       Date:  2016-01       Impact factor: 7.794

9.  Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes.

Authors:  Na Ra Kim; Jeong Min Lee; Se Hyung Kim; Su Kyung An; Chang Jin Han; Seung Hong Choi; Joon Koo Han; Hye Seung Lee; Ja Jun Jang; Byung Ihn Choi
Journal:  Clin Imaging       Date:  2008 Mar-Apr       Impact factor: 1.605

10.  Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker.

Authors:  Jisun Lee; Seong Hyun Kim; Tae Wook Kang; Kyoung Doo Song; Dongil Choi; Kee Taek Jang
Journal:  Radiology       Date:  2016-04-26       Impact factor: 11.105

View more
  11 in total

1.  18F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N- and M-staging: should guidelines recommend it at last?

Authors:  Maurizio Zizzo; Magda Zanelli; Francesca Sanguedolce; Annibale Versari; Pierpaolo Pattacini; Andrea Morini; Federica Mereu; Antonia Lavinia Zuliani; Alessandro Giunta
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

Review 2.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.

Authors:  Mei-Xia Zhang; Wei Gan; Chu-Yu Jing; Su-Su Zheng; Juan Zhang; Hu-Jia Shen; Xin Xu; Jia-Jia Lin; Bo-Heng Zhang; Shuang-Jian Qiu
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

4.  Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.

Authors:  Jana Taron; Jonas Johannink; Michael Bitzer; Konstantin Nikolaou; Mike Notohamiprodjo; Rüdiger Hoffmann
Journal:  Cancer Imaging       Date:  2018-03-07       Impact factor: 3.909

Review 5.  Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma.

Authors:  Nikolaos Serifis; Diamantis I Tsilimigras; Daniel J Cloonan; Timothy M Pawlik
Journal:  Hepat Med       Date:  2021-11-02

Review 6.  Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations.

Authors:  MacKenzie L Owen; Eliza W Beal
Journal:  Hepat Med       Date:  2021-12-22

7.  Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.

Authors:  Yi Wei; Feifei Gao; Dandan Zheng; Zixing Huang; Min Wang; Fubi Hu; Chenyang Chen; Ting Duan; Jie Chen; Likun Cao; Bin Song
Journal:  Oncotarget       Date:  2017-12-26

8.  Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions.

Authors:  Dietmar Tamandl; Ahmed Ba-Ssalamah; Gernot Böhm; Klaus Emmanuel; Rosemarie Forstner; Reinhold Függer; Benjamin Henninger; Oliver Koch; Claus Kölblinger; Hans-Jörg Mischinger; Wolfgang Schima; Helmut Schöllnast; Stefan Stättner; Klaus Kaczirek
Journal:  Wien Klin Wochenschr       Date:  2018-08-30       Impact factor: 1.704

9.  S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.

Authors:  Mei-Xia Zhang; Wei Gan; Chu-Yu Jing; Su-Su Zheng; Yong Yi; Juan Zhang; Xin Xu; Jia-Jia Lin; Bo-Heng Zhang; Shuang-Jian Qiu
Journal:  Mol Carcinog       Date:  2018-10-21       Impact factor: 4.784

10.  Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics.

Authors:  Mario Silva; Michele Maddalo; Eleonora Leoni; Sara Giuliotti; Gianluca Milanese; Caterina Ghetti; Elisabetta Biasini; Massimo De Filippo; Gabriele Missale; Nicola Sverzellati
Journal:  Abdom Radiol (NY)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.